EX-23.2 2 d476668dex232.htm EX-23.2

Exhibit 23.2

Consent of Independent Registered Public Accounting Firm

We hereby consent to the use in the Prospectus constituting a part of this Registration Statement on Form S-4 of our report dated April 17, 2024, relating to the financial statements of Bellevue Life Sciences Acquisition Corp., as of December 31, 2023 and 2022 and for the years then ended, which is contained in that Prospectus. We also consent to the reference to our firm under the caption “Experts” in the Prospectus.

/s/ WithumSmith+Brown, PC

New York, New York

June 28, 2024